Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2003
04/29/2003US6555323 Assay for ABCA1
04/29/2003US6555320 Classifying a rheumatoid arthritis condition as diffuse, follicular, or granulomatous based on binding of cytokines; immunoassay kit with reference chart
04/29/2003US6555315 Capturing genes potentially encoding novel biochemical pathways of interest in prokaryotic systems, and screening for these pathways using high throughput screening assays
04/29/2003US6555314 "Toso" is a member of the immunoglobulin gene superfamily and specifically inhibits Fas and TNF receptor family mediated apoptosis
04/29/2003US6555313 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
04/29/2003US6555091 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses
04/29/2003US6555066 Multicell test apparatus, each cell contains an anticoagulant and a clotting activator, and at least one cell includes a platelet inactivating agent; platelet inhibition test
04/29/2003US6555065 Automatic hematologic counting and analysing device
04/29/2003US6555064 Measuring blood coagulation time
04/29/2003US6555063 Cold crucible levitation-melting means; induction coil for generating a repulsion from the sidewall surface and passing a high frequency current for melting; container for maintaining a non-oxidizing atmosphere
04/29/2003US6555062 Specifically suited for performing heterogeneous binding assay protocols, particularly immunoassays.
04/29/2003US6555061 Multi-layer reagent test strip
04/29/2003US6554985 Methods and formulations for the separation of biological macromolecules
04/29/2003US6554788 Accurate measurement of hematocrit during blood recovery or plasma sequestration processes by means of algorithms to account for the presence of air or other non-blood substances in salvaged or separated blood
04/29/2003US6554609 Nanotechnology for electrical devices
04/29/2003US6553852 Apparatus and process for an off-surface cone penetrometer sensor
04/29/2003US6553848 Sampling devices
04/29/2003US6553814 Method and device for determining the hardness/elasticity and/or other properties of vegetables or fruit
04/29/2003US6553812 Combined oil quality and viscosity sensing system
04/29/2003CA2409530A1 Workpiece defect detection sensor
04/29/2003CA2234690C Detection of nucleic acids by fluorescence quenching
04/29/2003CA2214155C Method for determining true boiling point for crude oils
04/29/2003CA2170674C Method and apparatus for measuring octane number
04/29/2003CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
04/29/2003CA2105804C Kainate-binding, human cns receptors of the eaa5 family
04/29/2003CA2041800C On-line iron (ii) concentration monitoring to continuously determine corrosion in boiler systems
04/26/2003CA2407207A1 Thermosetting composition remaining-gel time assessment method
04/24/2003WO2003034319A1 Predicting quality of meat and/or meat yield of an animal carcass
04/24/2003WO2003034101A1 Substrate coated with a transparent organic film and method for making same
04/24/2003WO2003034076A1 Article handling system and method
04/24/2003WO2003034075A1 Universal microscope slide cassette
04/24/2003WO2003034074A1 Sensitivity controls for blood serology prepared from modified cells
04/24/2003WO2003034073A2 Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells
04/24/2003WO2003034072A2 Diagnosis and therapy of conditions involving alms1
04/24/2003WO2003034071A2 A method of forming a dynamic combinatorial library using a scaffold
04/24/2003WO2003034070A2 Immunohistological representation of fibrogenesis in histological tissue cuts
04/24/2003WO2003034069A2 Tcmp 03 protein for use in cancer therapy
04/24/2003WO2003034068A1 Localization of disorders associated with kallikreins
04/24/2003WO2003034067A1 Modulation of tor
04/24/2003WO2003034066A1 Method of diagnosing cerebral infarction
04/24/2003WO2003034065A2 Drug rescue by redesign of admet/pk properties
04/24/2003WO2003034064A2 Image analysis of high-density synthetic dna microarrays
04/24/2003WO2003034063A1 Method of screening remedy for atrial fibrillation
04/24/2003WO2003034062A1 Apparatus for judging constitution
04/24/2003WO2003034060A1 Apparatus and method for concurrently monitoring active release and physical appearance of solid dosage form pharmaceuticals
04/24/2003WO2003034059A1 Apparatus and process for analyzing cuts of meat
04/24/2003WO2003034057A2 Continuous on-line carbon analyzer
04/24/2003WO2003034056A1 Ion selective electrodes for direct organic drug analysis in saliva, sweat, and surface wipes
04/24/2003WO2003034055A1 Concentration measuring method and concentration measuring device
04/24/2003WO2003034043A2 Molecularly imprinted polymer solution anion sensor
04/24/2003WO2003034038A2 Flow control metering system and method for controlling filtration of liquid-based specimens
04/24/2003WO2003034037A2 Apparatus and method for destacking articles
04/24/2003WO2003034036A1 Apparatus and method for mixing specimens in vials
04/24/2003WO2003034035A1 Vial system and method for processing liquid-based specimens
04/24/2003WO2003034034A2 Automated system and method for processing multiple liquid-based specimens
04/24/2003WO2003034031A2 Highly sensitive methods for protein detection in proteomics
04/24/2003WO2003034028A2 Methods for identifying and using modulators of estrogen related receptor gamma
04/24/2003WO2003034027A2 Whole cell assay
04/24/2003WO2003034026A2 Microwell biochip
04/24/2003WO2003034024A2 Methods and apparatuses for analyzing biological samples by mass spectrometry
04/24/2003WO2003033743A1 System and method for temperature gradient capillary electrophoresis
04/24/2003WO2003033738A2 Polymorphic marker that can be used to assess the efficacy of interferon therapy
04/24/2003WO2003033737A1 Gene detection method using human mitochondrial dna
04/24/2003WO2003033731A2 Methods for detecting ovarian cancer
04/24/2003WO2003033730A1 Method for measurement using sodium azide
04/24/2003WO2003033729A1 Method of pre-treating sample for measuring saccharified amine and method of measuring saccharified amine
04/24/2003WO2003033728A1 Apparatus and method for detecting undesired residues in a sample
04/24/2003WO2003033727A1 Method of screening cell death inhibitor
04/24/2003WO2003033722A2 Nucleic acid amplification methods
04/24/2003WO2003033721A2 Proteomic interaction and genomic action determinations in the presence of associated redox state conditions
04/24/2003WO2003033710A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor
04/24/2003WO2003033704A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light
04/24/2003WO2003033695A1 Method of purifying recombinant fused protein and method of producing protein using the same
04/24/2003WO2003033691A1 Cellular microchip and the use thereof for method for examining living cells
04/24/2003WO2003033680A2 Kinases and phosphatases
04/24/2003WO2003033674A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity
04/24/2003WO2003033672A2 Nr3b nmda receptor subunit compositions and related methods
04/24/2003WO2003033670A2 Method for preparation of single chain antibodies
04/24/2003WO2003033669A2 Methods for screening and identifying host pathogen defense genes
04/24/2003WO2003033667A2 Use of mx gtpases in the prognosis and treatment of cancer
04/24/2003WO2003033664A2 Bone anti-resorptive compounds
04/24/2003WO2003033663A2 Rankl mimics and uses thereof
04/24/2003WO2003033660A2 9136, a human aldehyde dehydrogenase family member and uses therefor
04/24/2003WO2003033657A2 Antisense antiviral agent and method for treating ssrna viral infection
04/24/2003WO2003033656A2 MSREBPs AS MODIFIERS OF THE SREBP PATHWAY AND METHODS OF USE
04/24/2003WO2003033650A2 Recombinant renilla reniformis system for bioluminescence resonance energy transfer
04/24/2003WO2003033539A1 Composition for polymerising immobilisation of biological molecules and method for producing said composition
04/24/2003WO2003033533A1 Microfluidized leishmania antigen and methods of making and using thereof
04/24/2003WO2003033529A2 Tr4, tr4 activators, tr4 inhibitors or tr4-associated molecules for treating leukaemic diseases
04/24/2003WO2003033520A2 Anticancer vaccine and diganostic methods and reagents
04/24/2003WO2003033513A1 Differentially expressed genes associated with obesity and type 2 diabetes
04/24/2003WO2003033499A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
04/24/2003WO2003033437A2 A method of forming neuraminidase inhibitors by dynamic combinatorial chemistry and compounds obtained
04/24/2003WO2003033394A1 Container uncapping apparatus and method
04/24/2003WO2003033159A1 Magnetic particles
04/24/2003WO2003033149A2 Systems and methods for performing multiple diagnostic tests
04/24/2003WO2003033096A2 Method and separating module for the separation of particles from a dispersion, in particular of blood corpuscles from blood
04/24/2003WO2003033009A2 Novel drug targets for arthritis
04/24/2003WO2003033003A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator
04/24/2003WO2003032948A2 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
1 ... 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 ... 3937